The Ostase BAP Immunoenzymetric Assay is an in vitro device indicated for the quantitative measurement

of bone-specific alkaline phosphatase (BAP), an indicator of osteoblastic activity, in human serum.

This device is intended to be used as an aid in the management of postmenopausal osteoporosis and

Paget’s disease.